Vascular barrier protective effects of phlorotannins on HMGB1-mediated proinflammatory responses in vitro and in vivo

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 2188-2195

  Kim, Tae Hoon ^a   Ku, Sae Kwang ^a   Lee, Taeho ^b   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Endothelium; Hydroxyl group; Phlorotannins; Vascular barrier integrity

Indexed keywords

ACETIC ACID; CARBOXYMETHYLCELLULOSE; DIECKOL; ECKOL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYL GROUP; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; PHLOROGLUCINOL; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE MIGRATION INHIBITION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BENZOFURANS; BLOOD VESSELS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL SURVIVAL; DIOXINS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; KELP; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; PHLOROGLUCINOL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANNINS; TOLL-LIKE RECEPTOR 4;

EISENIA BICYCLIS; MUS;

EID: 84860343717     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.082     Document Type: Article

References (44)

1. Aggarwal B.B., Ichikawa H., Garodia P., Weerasinghe P., Sethi G., Bhatt I.D., Pandey M.K., Shishodia S., Nair M.G. From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin. Ther. Targets 2006, 10:87-118.
2. Akeson A.L., Woods C.W. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J. Immunol. Methods 1993, 163:181-185.
3. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
4. Bae J.S., Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 2008, 100:101-109.
5. Bae J.S., Rezaie A.R. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 2011, 118:3952-3959.
6. Bae J.S., Yang L., Manithody C., Rezaie A.R. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J. Biol. Chem. 2007, 282:9251-9259.
7. Bae J.W., Bae J.S. Barrier protective effects of lycopene in human endothelial cells. Inflamm. Res. 2011, 60:751-758.
8. Bustin M., Lehn D.A., Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1990, 1049:231-243.
9. Cantor J.M., Ginsberg M.H., Rose D.M. Integrin-associated proteins as potential therapeutic targets. Immunol. Rev. 2008, 223:236-251.
10. Che W., Lerner-Marmarosh N., Huang Q., Osawa M., Ohta S., Yoshizumi M., Glassman M., Lee J.D., Yan C., Berk B.C., Abe J. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 2002, 90:1222-1230.
11. El Gazzar M. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm. Res. 2007, 56:162-167.
12. Fisher M. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev. Neurol. Dis. 2008, 5(Suppl. 1):S4-S11.
13. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
14. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 1994, 127:1617-1626.
15. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 2006, 6:508-519.
16. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
17. Jung H.A., Oh S.H., Choi J.S. Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorg. Med. Chem. Lett. 2010, 20:3211-3215.
18. Kim D.C., Lee W., Bae J.S. Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflamm. Res. 2011, 60:1161-1168.
19. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 2001, 276:7614-7620.
20. Kim T.H., Bae J.S. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food Chem. Toxicol. 2010, 48:1682-1687.
21. Kim T.H., Ku S.K., Bae J.S. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food Chem. Toxicol. 2011, 50:1118-1123.
22. Kohyama N., Nagata T., Fujimoto S., Sekiya K. Inhibition of arachidonate lipoxygenase activities by 2-(3,4-dihydroxyphenyl)ethanol, a phenolic compound from olives. Biosci. Biotechnol. Biochem. 1997, 61:347-350.
23. Koivikko R., Loponen J., Pihlaja K., Jormalainen V. High-performance liquid chromatographic analysis of phlorotannins from the brown alga Fucus vesiculosus. Phytochem. Anal. 2007, 18:326-332.
24. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim. Biophys. Acta 1984, 792:92-97.
25. Lin W.N., Luo S.F., Wu C.B., Lin C.C., Yang C.M. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway. Toxicol. Appl. Pharmacol. 2008, 228:256-268.
26. Mullins G.E., Sunden-Cullberg J., Johansson A.S., Rouhiainen A., Erlandsson-Harris H., Yang H., Tracey K.J., Rauvala H., Palmblad J., Andersson J., Treutiger C.J. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand. J. Immunol. 2004, 60:566-573.
27. Nagayama K., Iwamura Y., Shibata T., Hirayama I., Nakamura T. Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. J. Antimicrob. Chemother. 2002, 50:889-893.
28. Okada Y., Ishimaru A., Suzuki R., Okuyama T. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J. Nat. Prod. 2004, 67:103-105.
29. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-879.
30. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
31. Qin Y.H., Dai S.M., Tang G.S., Zhang J., Ren D., Wang Z.W., Shen Q. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J. Immunol. 2009, 183:6244-6250.
32. Ruiz-Torres M.P., Perez-Rivero G., Rodriguez-Puyol M., Rodriguez-Puyol D., Diez-Marques M.L. The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins. Cell. Physiol. Biochem. 2006, 17:221-232.
33. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 2000, 11:4131-4142.
34. Sama A.E., D'Amore J., Ward M.F., Chen G., Wang H. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad. Emerg. Med. 2004, 11:867-873.
35. Stevenson B.R. Understanding tight junction clinical physiology at the molecular level. J. Clin. Invest. 1999, 104:3-4.
36. Sun C., Liang C., Ren Y., Zhen Y., He Z., Wang H., Tan H., Pan X., Wu Z. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res. Cardiol. 2009, 104:42-49.
37. Treutiger C.J., Mullins G.E., Johansson A.S., Rouhiainen A., Rauvala H.M., Erlandsson-Harris H., Andersson U., Yang H., Tracey K.J., Andersson J., Palmblad J.E. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 2003, 254:375-385.
38. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
39. Wang H., Yang H., Czura C.J., Sama A.E., Tracey K.J. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 2001, 164:1768-1773.
40. Wolfson R.K., Chiang E.T., Garcia J.G. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc. Res. 2011, 81:189-197.
41. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Nat. Acad. Sci. USA 2004, 101:296-301.
42. Yang H., Tracey K.J. Targeting HMGB1 in inflammation. Biochim. Biophys. Acta 2010, 1799:149-156.
43. Yang H., Wang H., Czura C.J., Tracey K.J. The cytokine activity of HMGB1. J. Leukoc. Biol. 2005, 78:1-8.
44. Yang J.A., Choi J.H., Rhee S.J. Effects of green tea catechin on phospholipase A2 activity and antithrombus in streptozotocin diabetic rats. J. Nutr. Sci. Vitaminol. (Tokyo) 1999, 45:337-346.